Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2026-01-09 @ 11:40 PM
Study NCT ID:
NCT03277105
Status:
COMPLETED
Last Update Posted:
2025-04-29
First Post:
2017-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-27
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-12
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-07
First Submit QC Date:
None
Study First Post Date:
2017-09-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-06-19
Results First Submit QC Date:
None
Results First Post Date:
2020-07-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-25
Last Update Post Date:
2025-04-29
Last Update Post Date Type:
ACTUAL